EBRO 2017

Epidemiology of esophageal cancer

EBRO 2017

• 6 th leading cause of cancer-related mortality • 8 th most common cancer worldwide • Worldwide >450,000 people are affected • Overall 5-year survival 15-25% • Diagnosis at advanced (metastatic) stages • 30-40% present with resectable disease

• SCC is predominant type; in some western European countries adenocarcinoma exceeds SCC